Skip to main content
Journal cover image

Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.

Publication ,  Journal Article
Perkins, D; Lieberman, J; Gu, H; Tohen, M; McEvoy, J; Green, A; Zipursky, R; Strakowski, S; Sharma, T; Kahn, R; Gur, R; Tollefson, G ...
Published in: Br J Psychiatry
July 2004

BACKGROUND: Duration of untreated psychosis (DUP) may contribute to the observed heterogeneity of the treatment response in first-episode schizophrenia. AIMS: To examine the relationship of DUP and premorbid function with clinical outcomes following up to 2 years of antipsychotic treatment. METHOD: For a subsample (n=191) of subjects participating in a clinical trial, DUP and premorbid function were prospectively compared with clinical response to olanzapine or haloperidol. RESULTS: Shorter DUP and good premorbid function each independently are associated with better clinical response, including improvement in overall psychopathology and negative symptoms. Premorbid function also is associated with positive symptom, social and vocational outcomes. CONCLUSIONS: Earlier antipsychotic treatment is associated with better outcomes in first-episode schizophrenia. Poor premorbid function could indicate an illness subtype less likely to respond to antipsychotic treatment regardless of when it is instituted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Psychiatry

DOI

ISSN

0007-1250

Publication Date

July 2004

Volume

185

Start / End Page

18 / 24

Location

England

Related Subject Headings

  • Treatment Outcome
  • Schizophrenia
  • Remission Induction
  • Psychotic Disorders
  • Psychiatry
  • Psychiatric Status Rating Scales
  • Prognosis
  • Olanzapine
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Perkins, D., Lieberman, J., Gu, H., Tohen, M., McEvoy, J., Green, A., … HGDH Research Group, . (2004). Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry, 185, 18–24. https://doi.org/10.1192/bjp.185.1.18
Perkins, Diana, Jeffrey Lieberman, Hongbin Gu, Mauricio Tohen, Joseph McEvoy, Alan Green, Robert Zipursky, et al. “Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.Br J Psychiatry 185 (July 2004): 18–24. https://doi.org/10.1192/bjp.185.1.18.
Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry. 2004 Jul;185:18–24.
Perkins, Diana, et al. “Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.Br J Psychiatry, vol. 185, July 2004, pp. 18–24. Pubmed, doi:10.1192/bjp.185.1.18.
Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Kahn R, Gur R, Tollefson G, HGDH Research Group. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry. 2004 Jul;185:18–24.
Journal cover image

Published In

Br J Psychiatry

DOI

ISSN

0007-1250

Publication Date

July 2004

Volume

185

Start / End Page

18 / 24

Location

England

Related Subject Headings

  • Treatment Outcome
  • Schizophrenia
  • Remission Induction
  • Psychotic Disorders
  • Psychiatry
  • Psychiatric Status Rating Scales
  • Prognosis
  • Olanzapine
  • Male
  • Humans